Wolverine Trading’s Jazz Pharmaceuticals JAZZ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-8,988
Closed -$1.11M 5288
2024
Q4
$1.11M Buy
8,988
+3,134
+54% +$369K ﹤0.01% 2559
2024
Q3
$649K Buy
5,854
+3,311
+130% +$363K ﹤0.01% 2799
2024
Q2
$271K Buy
+2,543
New +$280K ﹤0.01% 3507
2024
Q1
Sell
-3,949
Closed -$484K 4872
2023
Q4
$486K Buy
3,949
+1,956
+98% +$244K ﹤0.01% 2982
2023
Q3
$258K Buy
+1,993
New +$266K ﹤0.01% 3469
2022
Q1
Sell
-1,835
Closed -$266K 5923
2021
Q4
$235K Sell
1,835
-5,211
-74% -$685K ﹤0.01% 4469
2021
Q3
$927K Sell
7,046
-3,526
-33% -$533K ﹤0.01% 3088
2021
Q2
$1.89M Buy
+10,572
New +$1.83M ﹤0.01% 2034
2021
Q1
Sell
-8,213
Closed -$1.35M 6146
2020
Q4
$1.35M Buy
8,213
+1
+0% +$149 ﹤0.01% 2079
2020
Q3
$1.15M Buy
+8,212
New +$1.02M ﹤0.01% 1948
2020
Q2
Sell
-4,806
Closed -$531K 4903
2020
Q1
$479K Buy
+4,806
New +$621K ﹤0.01% 2702
2018
Q4
Sell
-2,328
Closed -$345K 4906
2018
Q3
$391K Buy
+2,328
New +$400K ﹤0.01% 3413
2017
Q2
Sell
-2,370
Closed -$362K 4626
2017
Q1
$345K Buy
+2,370
New +$309K ﹤0.01% 2850

Other funds holding JAZZ

Wolverine Trading's JAZZ Position: Q1 2025 in Review

Wolverine Trading sold out of Jazz Pharmaceuticals (JAZZ) in Q1 2025, closing a stake of 8,988 shares — an estimated $1.11M sold.

Wolverine Trading first reported a position in JAZZ in Q1 2017 and held it in 13 quarters. The position peaked at $1.89M in Q2 2021. 550 funds tracked by Wall St. Rank hold JAZZ as of Q1 2025.

  • Wolverine Trading reported no remaining Jazz Pharmaceuticals position as of Q1 2025 after selling out during the quarter.
  • Wolverine Trading sold 8,988 Jazz Pharmaceuticals shares in Q1 2025, an estimated $1.11M.
  • Wolverine Trading first reported a position in Jazz Pharmaceuticals in Q1 2017 and held it in 13 quarters.
  • Wolverine Trading's Jazz Pharmaceuticals position peaked at $1.89M in Q2 2021.
  • 550 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q1 2025.

Based on Wolverine Trading's 13F filing for Q1 2025, filed 15 May 2025.